Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women

Climacteric

Volumn 14, Issue 4, 2011, Pages 458-463

  Cerne, J Z ^a   Ferk, P ^b   Leskosek, B ^c   Gersak, K ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Breast cancer; Case control study; Epidemiology; Hormone replacement therapy; Risk factor

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST FEEDING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ESTROGEN THERAPY; ETHNICITY; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; OVARIECTOMY; OVARY CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SLOVENIA; SMOKING HABIT; TREATMENT DURATION;

AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; SLOVENIA; SMOKING;

EID: 79960453777     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2010.541307     Document Type: Article

References (30)

1. Cuzick J. Epidemiology of breast cancer-selected highlights. Breast 2003;12:405-11
2. ESHRE Capri Workshop Group. Hormones and breast cancer. Hum Reprod Update 2004;10:281-93
3. Kelsey JL, Berkowitz GS. Breast cancer epidemiology. Cancer Res 1988;48:5615-23
4. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 1993;15:17-35 (Pubitemid 23269068)
5. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;27:67-73
6. Collins JA, Blake JM, Crosignani PG. Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update 2005;11:545-60 (Pubitemid 41631306)
7. Skouby SO, Al-Azzawi F, Barlow D, et al. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements in peri-and postmenopausal hormone replacement therapy. Maturitas 2005;51:8-14 (Pubitemid 40692593)
8. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
9. Sturdee DW, MacLennan AH. The pendulum swings back: estrogen is now beneficial if started at the right time. Climacteric 2006;9:73-4
10. La Vecchia C. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer. Breast 2004;13: 515-18 (Pubitemid 39618825)
11. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl Med 2006;354:270-82
12. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrin Metab 1999;84:4559-65
13. Druckmann R. Progestins and their effects on the breast. Maturitas 2003;46(Suppl 1):S59-69 (Pubitemid 37506064)
14. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 2004;6:213-18
15. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16 (Pubitemid 34498648)
16. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. VI. Lyon: International Agency for Research on Cancer Scientific, 1992
17. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-27 (Pubitemid 23333614)
18. Kliewer E, Smith K. Breast cancer mortality among immigrants in Australia and Canada. J Natl Cancer Inst 1995;87: 1154-61
19. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2001. Bethesda, MD: National Cancer Institute, 2004 [http://seer.cancer. gov/csr/1975-2001/]
20. Hermon C, Beral V. Breast cancer mortality rates are leveling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. Br J Cancer 1996;73: 955-60 (Pubitemid 26110171)
21. Finley C, Gregg EV, Solomon LJ, Gay E. Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Commun Health 2001;26:39-50 (Pubitemid 33638551)
22. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer, hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27
23. McDowell MA, Brody DJ, Hughes JP. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J Adolesc Health 2007;40:227-31
24. Nicols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM. From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol 2006;164: 1003-11 (Pubitemid 44729843)
25. Matthews TJ, Hamilton BE. Mean age of mother, 1970-2000. Natl Vital Stat Rep 2002;51:1-16
26. Kaplowitz PB. Link between body fat and the timing of puberty. Pediatrics 2008;121(Suppl 3):S208-17
27. Ortiz AP, Harlow SD, Sowers M, Nan B, Romaguera J. Age at natural menopause and factors associated with menopause state among Puerto Rican women aged 40-59 years, living in Puerto Rico. Menopause 2006;13:116-24
28. Hardy R, Mishra GD, Kuh D. Body mass index trajectories and age at menopause in a British birth cohort. Maturitas 2008;59: 304-14
29. Lacey JV Jr, Kreimer AR, Buys SS, et al. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer 2009;9:84
30. Kelsey JL, Berstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996;17:47-67 (Pubitemid 26146345)